Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition (Q37253319)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 June 2009
edit
Language Label Description Also known as
English
Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition
scientific article published on 23 June 2009

    Statements

    Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition (English)
    Alexandra C Racanelli
    Cortney L Heyer
    Richard G Moran
    23 June 2009
    5467-5474

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit